2022
DOI: 10.1016/j.bjane.2021.02.062
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of dexmedetomidine anesthesia-related temperature changes: preliminary retrospective observational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 28 publications
0
1
0
Order By: Relevance
“…In humans, dexmedetomidine has been reported to cause hyperthermia; however, the mechanism is not fully known. 36 Perhaps the initial vasoconstriction that generally results from alpha-2 administration resulted in diminished heat loss earlier in the anesthetic monitoring period in the current study, resulting in higher temperatures in the AKD group over the AKM group. 37 Depth of anesthesia was evaluated in this study based on the reflexes monitored during the anesthetic period.…”
Section: Discussionmentioning
confidence: 70%
“…In humans, dexmedetomidine has been reported to cause hyperthermia; however, the mechanism is not fully known. 36 Perhaps the initial vasoconstriction that generally results from alpha-2 administration resulted in diminished heat loss earlier in the anesthetic monitoring period in the current study, resulting in higher temperatures in the AKD group over the AKM group. 37 Depth of anesthesia was evaluated in this study based on the reflexes monitored during the anesthetic period.…”
Section: Discussionmentioning
confidence: 70%
“…The accelerated decline in BT is due to the drop in basal metabolism, which is primarily responsible for thermoregulation, and to exposure to the colder environment (Nascimento et al, 2021). The agonistic action of dexmedetomidine on the central α-2 receptor reduces vasoconstriction/ shivering thresholds and physiological responses for increasing BT (Cruz et al, 2022). Butorphanol has a weak effect on BT (Miller & Fowler, 2012;Thomas & Lerche, 2017), but drug interactions of this opioid cannot be ruled out.…”
Section: Btmentioning
confidence: 99%